Corvidia Therapeutics
Waltham, US · Founded 2014 · 3 known investors
Find your way into Corvidia Therapeutics
Founders & leadership
MD
MARC DE GARIDELinChief Executive Officer
RA
RAM AIYARExecutive
Board
AK

KH
KARIM HELMYBoard director
TR
TYRELL RIVERSBoard director
GS

SG
SYLVIE GREGOIREBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$60M disclosed across 1 round · 2018
▶$60MraisedMay 2018 · 15 investors · BiotechnologyRule 506(b)
▶$60MraisedMay 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- AARON KANTOFFDirector
- KARIM HELMYDirector
- MARC DE GARIDELExecutive Officer, Director
- SYLVIE GREGOIREDirector
- TYRELL RIVERSDirector
- GRAZIANO SEGHEZZIDirector
- RAM AIYARExecutive Officer
- Offering amount
- $60M
- Amount sold
- $60M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Corvidia Therapeutics's investors?
- Corvidia Therapeutics's investors include Andera Partners, Scion Life Sciences, Sofinnova Partners.
- How much funding has Corvidia Therapeutics raised?
- Corvidia Therapeutics has disclosed $60M raised across 1 round.
- Where is Corvidia Therapeutics headquartered?
- Corvidia Therapeutics is headquartered in Waltham, US.